Literature DB >> 20851608

Management of recurrent Cushing's disease.

Simon V Liubinas1, Lana Del Porto, Andrew H Kaye.   

Abstract

The management of patients with Cushing's disease remains a major challenge. The remission rate for initial transsphenoidal surgery is reported as 69-94% while the recurrence rate following initially successful transsphenoidal surgery is 2-27%. Treatment options for Cushing's disease after failed initial therapy or recurrence include repeat transsphenoidal surgery, radiotherapy, medical therapy and bilateral adrenalectomy. Management options following unsuccessful initial surgery or recurrence are presented and discussed. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20851608     DOI: 10.1016/j.jocn.2010.05.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  Medical management of Cushing's disease.

Authors:  Nicholas A Tritos; Beverly M K Biller
Journal:  J Neurooncol       Date:  2013-10-22       Impact factor: 4.130

3.  Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.

Authors:  Li Du; Marvin Bergsneider; Leili Mirsadraei; Steven H Young; Johan W Jonker; Michael Downes; William H Yong; Ronald M Evans; Anthony P Heaney
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-07       Impact factor: 11.205

4.  Targeting the ERK pathway for the treatment of Cushing's disease.

Authors:  Dongyun Zhang; Marvin Bergsneider; Marilene B Wang; Anthony P Heaney
Journal:  Oncotarget       Date:  2016-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.